Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Roberts

Showing results (441-450 of 682) with videos related to

Pageof 69
Sort By:
European Journal of Clinical Pharmacology|September 25, 2020
Ceftriaxone dosing in patients admitted from the emergency department with sepsisAaron J Heffernan, Rebecca A Curran, Kerina J Denny, et al.
BMC Anesthesiology|February 22, 2011
Antibiotic dosing in the 'at risk' critically ill patient: Linking pathophysiology with pharmacokinetics/pharmacodynamics in sepsis and trauma patientsJason A Roberts, Michael S Roberts, Andrew Semark, et al.
Australian Health Review : a Publication of the Australian Hospital Association|November 8, 2014
Antimicrobial stewardship activities: a survey of Queensland hospitalsMinyon L Avent, Lisa Hall, Louise Davis, et al.
Antimicrobial Agents and Chemotherapy|May 6, 2026
Evaluating the efficacy of ceftazidime/avibactam plus amikacin combination therapy as a carbapenem-sparing agent against ceftazidime/avibactam-resistant <i>Escherichia coli</i> using a hollow fiber infection model: a proof-of-concept studyMikaela M Walker, Jason A Roberts, Yixuan Li, et al.
Bioanalysis|July 7, 2020
Kidney transplant recipient's perceptions of blood testing through microsampling and venepunctureCarla E Scuderi, Suzanne L Parker, Margaret Jacks, et al.
Drugs in R&D|April 2, 2021
Impact of the Epithelial Lining Fluid Milieu on Amikacin Pharmacodynamics Against Pseudomonas aeruginosaAaron J Heffernan, Fekade B Sime, Sazlyna Mohd Sazlly Lim, et al.
Clinical Pharmacokinetics|February 28, 2023
Population Pharmacokinetics and Dosing Simulations of Ampicillin and Sulbactam in Hospitalised Adult PatientsEko Setiawan, Menino Osbert Cotta, Mohd-Hafiz Abdul-Aziz, et al.
International Journal of Antimicrobial Agents|April 18, 2015
Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administrationJanattul-Ain Jamal, Darren M Roberts, Andrew A Udy, et al.
The Journal of Antimicrobial Chemotherapy|May 9, 2015
Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trialFekade Bruck Sime, Michael S Roberts, Ing Soo Tiong, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2022
Multicenter Population Pharmacokinetic Study of Unbound Ceftriaxone in Critically Ill PatientsAaron J Heffernan, Fekade B Sime, Nilesh Kumta, et al.
Pageof 69

Showing results (441-450 of 682) with videos related to

Sort By:
Pageof 69
European Journal of Clinical Pharmacology|September 25, 2020
Ceftriaxone dosing in patients admitted from the emergency department with sepsisAaron J Heffernan, Rebecca A Curran, Kerina J Denny, et al.
BMC Anesthesiology|February 22, 2011
Antibiotic dosing in the 'at risk' critically ill patient: Linking pathophysiology with pharmacokinetics/pharmacodynamics in sepsis and trauma patientsJason A Roberts, Michael S Roberts, Andrew Semark, et al.
Australian Health Review : a Publication of the Australian Hospital Association|November 8, 2014
Antimicrobial stewardship activities: a survey of Queensland hospitalsMinyon L Avent, Lisa Hall, Louise Davis, et al.
Antimicrobial Agents and Chemotherapy|May 6, 2026
Evaluating the efficacy of ceftazidime/avibactam plus amikacin combination therapy as a carbapenem-sparing agent against ceftazidime/avibactam-resistant <i>Escherichia coli</i> using a hollow fiber infection model: a proof-of-concept studyMikaela M Walker, Jason A Roberts, Yixuan Li, et al.
Bioanalysis|July 7, 2020
Kidney transplant recipient's perceptions of blood testing through microsampling and venepunctureCarla E Scuderi, Suzanne L Parker, Margaret Jacks, et al.
Drugs in R&D|April 2, 2021
Impact of the Epithelial Lining Fluid Milieu on Amikacin Pharmacodynamics Against Pseudomonas aeruginosaAaron J Heffernan, Fekade B Sime, Sazlyna Mohd Sazlly Lim, et al.
Clinical Pharmacokinetics|February 28, 2023
Population Pharmacokinetics and Dosing Simulations of Ampicillin and Sulbactam in Hospitalised Adult PatientsEko Setiawan, Menino Osbert Cotta, Mohd-Hafiz Abdul-Aziz, et al.
International Journal of Antimicrobial Agents|April 18, 2015
Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administrationJanattul-Ain Jamal, Darren M Roberts, Andrew A Udy, et al.
The Journal of Antimicrobial Chemotherapy|May 9, 2015
Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trialFekade Bruck Sime, Michael S Roberts, Ing Soo Tiong, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2022
Multicenter Population Pharmacokinetic Study of Unbound Ceftriaxone in Critically Ill PatientsAaron J Heffernan, Fekade B Sime, Nilesh Kumta, et al.
Pageof 69